Medicus Pharma Statistics

Total Valuation

Medicus Pharma has a market cap or net worth of $25.95 million. The enterprise value is $22.12 million.

Market Cap	25.95M
Enterprise Value	22.12M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, after market close.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Medicus Pharma has 56.66 million shares outstanding. The number of shares has increased by 102.71% in one year.

Current Share Class	56.66M
Shares Outstanding	56.66M
Shares Change (YoY)	+102.71%
Shares Change (QoQ)	+58.81%
Owned by Insiders (%)	6.01%
Owned by Institutions (%)	5.49%
Float	50.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.81
P/TBV Ratio	19.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 1.77.

Current Ratio	1.22
Quick Ratio	1.07
Debt / Equity	1.77
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-50.89

Financial Efficiency

Return on equity (ROE) is -2,865.18% and return on invested capital (ROIC) is -568.20%.

Return on Equity (ROE)	-2,865.18%
Return on Assets (ROA)	-278.12%
Return on Invested Capital (ROIC)	-568.20%
Return on Capital Employed (ROCE)	-1,976.28%
Weighted Average Cost of Capital (WACC)	2.97%
Revenue Per Employee	n/a
Profits Per Employee	-$3.20M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.22% in the last 52 weeks. The beta is -0.50, so Medicus Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.50
52-Week Price Change	-83.22%
50-Day Moving Average	0.34
200-Day Moving Average	1.30
Relative Strength Index (RSI)	64.91
Average Volume (20 Days)	2,478,919

Short Selling Information

The latest short interest is 2.98 million, so 5.27% of the outstanding shares have been sold short.

Short Interest	2.98M
Short Previous Month	2.19M
Short % of Shares Out	5.27%
Short % of Float	5.93%
Short Ratio (days to cover)	1.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.11M
Pretax Income	-51.22M
Net Income	-51.22M
EBITDA	n/a
EBIT	-29.11M
Earnings Per Share (EPS)	-$2.37

Full Income Statement

Balance Sheet

The company has $6.37 million in cash and $2.53 million in debt, giving a net cash position of $3.83 million or $0.07 per share.

Cash & Cash Equivalents	6.37M
Total Debt	2.53M
Net Cash	3.83M
Net Cash Per Share	$0.07
Equity (Book Value)	1.43M
Book Value Per Share	0.03
Working Capital	1.33M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-27.81M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	1.29M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medicus Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-102.71%
Shareholder Yield	-102.71%
Earnings Yield	-197.39%
FCF Yield	n/a

Analyst Forecast

The average price target for Medicus Pharma is $5.67, which is 1,137.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.67
Price Target Difference	1,137.99%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 25, 2024. It was a reverse split with a ratio of 1:2.

Last Split Date	Oct 25, 2024
Split Type	Reverse
Split Ratio	1:2

Scores

Altman Z-Score	n/a
Piotroski F-Score	1